Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

Bullboard Posts

Comment by longondmxon Sep 13, 2017 10:51am

97 Views

Post# 26689804

RE:RE:RE:RE:First Shipment of Bioreactor Antigen

Furthermore, to support at least a $0.70 share price, adding just $2 million to the profit of the company, and using 84.7 Million shares outstanding as he proxy, that alone is worth 11.6 cents per share. Even with a lousy 4X multiple, you are looking at $0.47 share price increase. Expect share price to accelerate this week and into next.

Bullboard Posts

Options trading in a volatile macro environment